A large international team of researchers claims to have finally sequenced the entire human genome. Collectively, the team is known as the Telomere-to-Telomere (T2T) Consortium, and they wrote a report describing their efforts and uploaded it to the bioRxiv prepress server.
As early as 2000, a team from the human genome project, working with biotechnology company Celera Genomics, announced that it had completed the first human genome sequence project. About 1
The researchers suggest that their work is only possible because they used a new technology developed by Oxford Nanopore and Pacific Biosciences – the new technology allows sequencing without cutting DNA into pieces. Instead, he passed DNA through a nanoscopic hole with lasers that read the sequences multiple times to reduce errors. They also claim that the number of known bases has now risen from 2.92 billion to 3.05 billion, and the number of known genes has increased by 0.4%.
The researchers also note that the genome they sequenced did not originate in humans, but rather hydatidiform, which is a growth that is rarely formed on the inside of a woman’s uterus. Such growths occur when the sperm manages to fertilize an egg that does not have a nucleus; thus it has only 23 chromosomes, not the normal 46 found in most human cells. The researchers chose to arrange the hydatid deformity because it made their calculations easier.
The results have yet to be reviewed by partners, so the genomic community has stopped commenting – meanwhile, the T2T team is making plans for further work by sequencing many people from around the world.
Scientists have achieved the first complete assembly of the human X chromosome
Sergei Nurk et al., The complete sequence of the human genome, bioRxiv (2021). DOI: 10.1101 / 2021.05.26.445798
© 2021 Science X Network
Quote: Researchers claim to have sequenced the entire human genome (2021, June 7) extracted on June 7, 2021 from https://phys.org/news/2021-06-sequenced-entire-human-genome.html
This document is subject to copyright. Except for any fair transaction for the purpose of private examination or research, no part may be reproduced without written permission. The content is provided for informational purposes only.